iPath Pure Beta Softs ETN
GRWN
GRWN was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $2K invested in iPath Pure Beta Softs ETN in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more capital invested
Capital invested by funds: $2K → $2K ($0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.05K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $2K | +$1.05K | +42 | +58% |
|
GRWN Hedge Fund Activity: Q1 2015 in Review
1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Softs ETN (GRWN) for Q1 2015, worth a combined $2K — unchanged from a quarter earlier.
Fund positioning in GRWN was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $1.05K.
- 1 institutional investor held iPath Pure Beta Softs ETN (GRWN) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $2K of iPath Pure Beta Softs ETN stock for Q1 2015, unchanged quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Softs ETN positions in Q1 2015 and 0 closed out.
- The largest iPath Pure Beta Softs ETN buyer in Q1 2015 was UBS Group, an estimated $1.05K added.
Based on aggregated 13F filings for Q1 2015.